These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26622994)

  • 21. Prevalence of hepatitis B virus infection among health care workers in a tertiary hospital in Tanzania.
    Mueller A; Stoetter L; Kalluvya S; Stich A; Majinge C; Weissbrich B; Kasang C
    BMC Infect Dis; 2015 Sep; 15():386. PubMed ID: 26399765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and significance of hepatitis B virus antigens: expression in peripheral blood mononuclear cells in chronic active hepatitis.
    Parvaz P; Lamelin JP; Vitvitski L; Bouffard P; Pichoud C; Cova L; Trepo C
    Clin Immunol Immunopathol; 1987 Apr; 43(1):1-8. PubMed ID: 3829455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population.
    Prieto M; Gómez MD; Berenguer M; Córdoba J; Rayón JM; Pastor M; García-Herola A; Nicolás D; Carrasco D; Orbis JF; Mir J; Berenguer J
    Liver Transpl; 2001 Jan; 7(1):51-8. PubMed ID: 11150423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody titration and immune response of Iranian beta-thalassemic patients to hepatitis B virus vaccine (booster effect).
    Azarkeivan A; Karimi G; Shaiegan M; Maghsudlu M; Tabbaroki A
    Pediatr Hematol Oncol; 2009 Jun; 26(4):195-201. PubMed ID: 19437322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HBV and HCV infection in Japanese dental care workers.
    Nagao Y; Matsuoka H; Kawaguchi T; Ide T; Sata M
    Int J Mol Med; 2008 Jun; 21(6):791-9. PubMed ID: 18506374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of HBc-Ab among HBs-Ag negative healthy blood donors in south of Iran.
    Khorami F; Sobhani SA; Davoudian P; Khajeh E
    Electron Physician; 2013; 5(3):659-63. PubMed ID: 26120400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Seroprevalence Study of Hepatitis B and C Virus Infections in a Hospitalized Population in Romania, an Opportunity for a Better National Prevention and Control Strategy.
    Popovici O; Molnar GB; Popovici F; Janţă D; Pistol A; Azoicăi D
    J Gastrointestin Liver Dis; 2016 Mar; 25(1):25-32. PubMed ID: 27014751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of occult hepatitis B virus infection among blood donors with isolated hepatitis B core antibody living in an HBV low prevalence region of Iran.
    Sofian M; Aghakhani A; Izadi N; Banifazl M; Kalantar E; Eslamifar A; Ramezani A
    Int J Infect Dis; 2010 Apr; 14(4):e308-10. PubMed ID: 19656713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequency of isolated hepatitis B core antibody in HIV-hepatitis C virus co-infected individuals.
    Ramezani A; Mohraz M; Aghakhani A; Banifazl M; Eslamifar A; Khadem-Sadegh A; Velayati AA
    Int J STD AIDS; 2009 May; 20(5):336-8. PubMed ID: 19386971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterisation and follow-up study of occult hepatitis B virus infection in anti-HBc-positive qualified blood donors in southern China.
    Ye X; Li T; Xu X; Du P; Zeng J; Zhu W; Yang B; Li C; Allain JP
    Blood Transfus; 2017 Jan; 15(1):6-12. PubMed ID: 27416568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are isolated anti-HBc blood donors in high risk group? The detection of HBV DNA in isolated anti-HBc cases with nucleic acid amplification test (NAT) based on transcription-mediated amplification (TMA) and HBV discrimination.
    Altunay H; Kosan E; Birinci I; Aksoy A; Kirali K; Saribas S; Aslan M; Yuksel P; Alan E; Yenen OS; Kocazeybek B
    Transfus Apher Sci; 2010 Dec; 43(3):265-268. PubMed ID: 20934912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transplantation of livers from hbc Ab positive donors into HBc Ab negative recipients: a strategy and preliminary results.
    Loss GE; Mason AL; Blazek J; Dick D; Lipscomb J; Guo L; Perrillo RP; Eason JD
    Clin Transplant; 2001; 15 Suppl 6():55-8. PubMed ID: 11903388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The assessment of hepatitis B seroprevalence in persons with intravenous drug use history in the Isfahan province: Community-based study.
    Khodadoostan M; Ataei B; Shavakhi A; Tavakoli T; Nokhodian Z; Yaran M
    J Res Med Sci; 2014 Jan; 19(1):65-8. PubMed ID: 24672567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infectivity of hepatic allografts with antibodies to hepatitis B virus.
    Dodson SF; Issa S; Araya V; Gayowski T; Pinna A; Eghtesad B; Iwatsuki S; Montalvo E; Rakela J; Fung JJ
    Transplantation; 1997 Dec; 64(11):1582-4. PubMed ID: 9415560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significance of screening antibodies to hepatitis B virus core antigen among Syrian blood donors.
    Muselmani W; Habbal W; Monem F
    Transfus Med; 2013 Aug; 23(4):265-8. PubMed ID: 23621787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased seroprevalence of HBV DNA with mutations in the s gene among individuals greater than 18 years old after complete vaccination.
    Lai MW; Lin TY; Tsao KC; Huang CG; Hsiao MJ; Liang KH; Yeh CT
    Gastroenterology; 2012 Aug; 143(2):400-7. PubMed ID: 22580098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation (retrospective study).
    Diop-Ndiaye H; Touré-Kane C; Etard JF; Lô G; Diaw P; Ngom-Gueye NF; Gueye PM; Ba-Fall K; Ndiaye I; Sow PS; Delaporte E; Mboup S
    J Med Virol; 2008 Aug; 80(8):1332-6. PubMed ID: 18551596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A case of hepatitis B virus reactivation in a patient with prior resolved hepatitis B infection during bevacizumab plus FOLFIRI treatment].
    Noguchi Y; Tsurushima M; Tamura Y; Aoyama K; Tokuyama Y; Uchiyama K; Shimizu Y
    Gan To Kagaku Ryoho; 2013 Nov; 40(11):1561-3. PubMed ID: 24231716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low prevalence of hepatitis B vaccine escape mutants among individuals born after the initiation of a nationwide vaccination program in Iran.
    Aghasadeghi MR; Velayati AA; Mamishi S; Nabavi M; Aghakhani A; Bidari-Zerehpoosh F; Haghi Ashtiani MT; Sabeti S; Banifazl M; Azimian-Zavareh F; Motevalli F; Soleymani S; Ramezani A
    Arch Virol; 2016 Dec; 161(12):3405-3411. PubMed ID: 27613286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prevalence and significance of isolated hepatitis B core antibody (anti-HBc) in endemic population.
    Hyun CS; Lee S; Ventura WR
    BMC Res Notes; 2019 May; 12(1):251. PubMed ID: 31060623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.